The BrightHeart team. Image: BrightHeart

BrightHeart, an AI company focused on prenatal ultrasound, has made its B-Right AI Platform available through GE HealthCare’s Voluson Solution Store, a digital marketplace for women’s health ultrasound available in the United States and Europe.

The platform provides AI support across the prenatal ultrasound exam, including fetal heart screening, anatomy tracking, and evaluations. BrightHeart says its technology has been clinically validated to improve congenital heart disease detection rates to over 96% while reducing diagnostic errors. The company cites two recent publications in The Green Journal supporting its clinical evidence.

More than 30% of congenital defects currently go undetected prenatally, and structural anomalies are identified in up to 6% of pregnancies. The United States is also facing a sonographer shortage and growing care deserts.

“Working closely with GE HealthCare allows us to deliver best-in-class AI tools exactly where clinicians need it within the workflows they already trust,” said Cécile Dupont, CEO of BrightHeart. “By combining our AI with Voluson ultrasound, we’re helping care teams perform more complete, efficient, and reproducible anatomy exams, reinforcing our shared commitment to elevate prenatal care.”

Gerald Seifriedsberger, General Manager of Women’s Health Ultrasound at GE HealthCare, said: “Making BrightHeart’s B-Right AI platform available through the Voluson Solution Store – the first digital marketplace for Women’s Health ultrasound – puts clinically validated AI directly into the hands of Voluson customers. It helps care teams perform more complete and consistent prenatal exams and supports significantly improved performance in congenital defect screening.”

The partnership follows BrightHeart’s €11 million Series A in January 2026, co-led by Odyssée Venture and GO Capital, which is funding US commercialization and European expansion. The Paris-based company achieved five FDA clearances in 2025 and is a portfolio company of Sofinnova MD Start, Sofinnova Partners’ medical device accelerator.

Show CommentsClose Comments

Leave a comment